BCM
AEON icon

Basso Capital Management’s AEON Biopharma AEON Stock Holding History

Basso Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-511
Closed -$363K – 76
2022
Q3 		$363K Sell
511
-20
-4% -$14.2K 0.09% 179
2022
Q2 		$375K Hold
531
– – 0.04% 367
2022
Q1 		$374K Hold
531
– – 0.04% 377
2021
Q4 		$371K Hold
531
– – 0.04% 313
2021
Q3 		$372K Hold
531
– – 0.04% 282
2021
Q2 		$368K Buy
+531
New +$371K 0.05% 294

Other funds holding AEON

ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Basso Capital Management's AEON Position: Q4 2022 in Review

Basso Capital Management sold out of AEON Biopharma (AEON) in Q4 2022, closing a stake of 511 shares — an estimated $363K sold.

Basso Capital Management first reported a position in AEON in Q2 2021 and held it in 6 quarters. The position peaked at $375K in Q2 2022. 85 funds tracked by Wall St. Rank hold AEON as of Q4 2022.

  • Basso Capital Management reported no remaining AEON Biopharma position as of Q4 2022 after selling out during the quarter.
  • Basso Capital Management sold 511 AEON Biopharma shares in Q4 2022, an estimated $363K.
  • Basso Capital Management first reported a position in AEON Biopharma in Q2 2021 and held it in 6 quarters.
  • Basso Capital Management's AEON Biopharma position peaked at $375K in Q2 2022.
  • 85 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.